CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma
Clinical trial NCT03427476 · COMPLETED
Trial details
- NCT number
- NCT03427476
- Sponsor
- Cancer Targeted Technology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2018-08-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.